Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.

Georgescu C, Corbin JM, Thibivilliers S, Webb ZD, Zhao YD, Koster J, Fung KM, Asch AS, Wren JD, Ruiz-Echevarría MJ.

BMC Cancer. 2019 May 6;19(1):423. doi: 10.1186/s12885-019-5592-6.

2.

Purification, characterization, and N-glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures.

Corbin JM, Kailemia MJ, Cadieux CL, Alkanaimsh S, Karuppanan K, Rodriguez RL, Lebrilla CB, Cerasoli DM, McDonald KA, Nandi S.

Biotechnol Bioeng. 2018 May;115(5):1301-1310. doi: 10.1002/bit.26557. Epub 2018 Feb 27.

PMID:
29411865
3.

One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling.

Corbin JM, Ruiz-Echevarría MJ.

Int J Mol Sci. 2016 Jul 27;17(8). pii: E1208. doi: 10.3390/ijms17081208. Review.

4.

Semicontinuous Bioreactor Production of Recombinant Butyrylcholinesterase in Transgenic Rice Cell Suspension Cultures.

Corbin JM, Hashimoto BI, Karuppanan K, Kyser ZR, Wu L, Roberts BA, Noe AR, Rodriguez RL, McDonald KA, Nandi S.

Front Plant Sci. 2016 Mar 31;7:412. doi: 10.3389/fpls.2016.00412. eCollection 2016.

5.

Analysis of TMEFF2 allografts and transgenic mouse models reveals roles in prostate regeneration and cancer.

Corbin JM, Overcash RF, Wren JD, Coburn A, Tipton GJ, Ezzell JA, McNaughton KK, Fung KM, Kosanke SD, Ruiz-Echevarria MJ.

Prostate. 2016 Jan;76(1):97-113. doi: 10.1002/pros.23103. Epub 2015 Sep 29.

6.

Robust, quantitative analysis of proteins using peptide immunoreagents, in vitro translation, and an ultrasensitive acoustic resonant sensor.

Jalali-Yazdi F, Corbin JM, Takahashi TT, Roberts RW.

Anal Chem. 2014 May 20;86(10):4715-22. doi: 10.1021/ac500084d. Epub 2014 May 2.

7.

The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells.

Chen X, Corbin JM, Tipton GJ, Yang LV, Asch AS, Ruiz-Echevarría MJ.

Biochim Biophys Acta. 2014 Jun;1843(6):1216-24. doi: 10.1016/j.bbamcr.2014.03.005. Epub 2014 Mar 13.

8.

The body in health and illness.

Corbin JM.

Qual Health Res. 2003 Feb;13(2):256-67.

PMID:
12643032
9.

Biological response to variation of acid-volatile sulfides and metals in field-exposed spiked sediments.

Boothman WS, Hansen DJ, Berry WJ, Robson DL, Helmstetter A, Corbin JM, Pratt SD.

Environ Toxicol Chem. 2001 Feb;20(2):264-72.

PMID:
11351425
10.

The Corbin and Strauss Chronic Illness Trajectory model: an update.

Corbin JM.

Sch Inq Nurs Pract. 1998 Spring;12(1):33-41. Review.

PMID:
9805470
11.

Controlling the risks of a medically complicated pregnancy.

Corbin JM.

J Perinat Neonatal Nurs. 1993 Dec;7(3):1-6. No abstract available.

PMID:
8246119
12.

A nursing model for chronic illness management based upon the Trajectory Framework.

Corbin JM, Strauss A.

Sch Inq Nurs Pract. 1991 Fall;5(3):155-74.

PMID:
1763239
13.

Women's perceptions and management of a pregnancy complicated by chronic illness.

Corbin JM.

Health Care Women Int. 1987;8(5-6):317-37. No abstract available.

PMID:
3693139
14.

Collaboration: couples working together to manage chronic illness.

Corbin JM, Strauss AL.

Image J Nurs Sch. 1984 Fall;16(4):109-15. No abstract available.

PMID:
6567581

Supplemental Content

Loading ...
Support Center